File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Case Report: Retinal Vasculitis in Two Adolescents After COVID-19 Vaccination

TitleCase Report: Retinal Vasculitis in Two Adolescents After COVID-19 Vaccination
Authors
KeywordsAdolescents
case report
COVID vaccination
COVID-19 mRNA vaccine
retinal vasculitis
Issue Date2023
Citation
Ocular Immunology and Inflammation, 2023, v. 31, n. 6, p. 1245-1249 How to Cite?
AbstractPurpose: To report two cases of bilateral retinal vasculitis in adolescents following COVID-19 vaccination. Study Design: Case report. Results:  We report the first two cases of retinal vasculitis in adolescents following COVID-19 vaccinations. Both patients received recent second-dose COVID-19 vaccinations (7 weeks and 4 weeks respectively), and presented with bilateral retinal vasculitis and vitritis. Investigations did not reveal other causes of retinal vasculitis. Both patients’ retinal vasculitis settled with a short course of oral prednisolone. Conclusion: Although rare, the temporal association between vaccination, bilateral eye involvement, and the absence of alternative infective or inflammatory causes, makes this a plausible etiology. mRNA vaccinations may cause an autoimmune reaction via host antigenic mimicry, and systemic vasculitis has previously been described. We believe that a short interval between COVID-19 vaccination doses might be a risk factor for the development of retinal vasculitis in adolescents, and clinicians should be aware to elicit vaccination history.
Persistent Identifierhttp://hdl.handle.net/10722/335890
ISSN
2023 Impact Factor: 2.6
2023 SCImago Journal Rankings: 0.836
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorMohamed, Shaheeda-
dc.contributor.authorChan, Carmen K.M.-
dc.contributor.authorTsang, Chi Wai-
dc.contributor.authorSzeto, Simon K.H.-
dc.contributor.authorFong, Angie H.C.-
dc.contributor.authorChan, Jason C.K.-
dc.contributor.authorWong, Cherie Y.K.-
dc.date.accessioned2023-12-28T08:49:30Z-
dc.date.available2023-12-28T08:49:30Z-
dc.date.issued2023-
dc.identifier.citationOcular Immunology and Inflammation, 2023, v. 31, n. 6, p. 1245-1249-
dc.identifier.issn0927-3948-
dc.identifier.urihttp://hdl.handle.net/10722/335890-
dc.description.abstractPurpose: To report two cases of bilateral retinal vasculitis in adolescents following COVID-19 vaccination. Study Design: Case report. Results:  We report the first two cases of retinal vasculitis in adolescents following COVID-19 vaccinations. Both patients received recent second-dose COVID-19 vaccinations (7 weeks and 4 weeks respectively), and presented with bilateral retinal vasculitis and vitritis. Investigations did not reveal other causes of retinal vasculitis. Both patients’ retinal vasculitis settled with a short course of oral prednisolone. Conclusion: Although rare, the temporal association between vaccination, bilateral eye involvement, and the absence of alternative infective or inflammatory causes, makes this a plausible etiology. mRNA vaccinations may cause an autoimmune reaction via host antigenic mimicry, and systemic vasculitis has previously been described. We believe that a short interval between COVID-19 vaccination doses might be a risk factor for the development of retinal vasculitis in adolescents, and clinicians should be aware to elicit vaccination history.-
dc.languageeng-
dc.relation.ispartofOcular Immunology and Inflammation-
dc.subjectAdolescents-
dc.subjectcase report-
dc.subjectCOVID vaccination-
dc.subjectCOVID-19 mRNA vaccine-
dc.subjectretinal vasculitis-
dc.titleCase Report: Retinal Vasculitis in Two Adolescents After COVID-19 Vaccination-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1080/09273948.2022.2129694-
dc.identifier.pmid36228169-
dc.identifier.scopuseid_2-s2.0-85139914103-
dc.identifier.volume31-
dc.identifier.issue6-
dc.identifier.spage1245-
dc.identifier.epage1249-
dc.identifier.eissn1744-5078-
dc.identifier.isiWOS:000867504500001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats